Distributed Diagnostics for the Last Mile
Business Models for Taking Diagnostic Screening to the Last Mile
India's opportunity in decentralized diagnostics is not just about developing portable, affordable, or faster technologies. It is about finding effective ways to make these technologies accessible to people who remain underserved by conventional diagnostic infrastructure.
The central question is how to embed diagnostic solutions within existing community networks, making screening more accessible while ensuring that results lead to appropriate care.
The investment opportunity lies at the intersection of diagnostic technology, community distribution and sustainable healthcare delivery.
Business models for community-level screening
Business model | How it works | What makes it viable |
|---|---|---|
Pharmacy-led access | Local pharmacies facilitate eligible screening, sample collection, or referrals. | Community trust, regular footfall, and sustainable partner economics. |
Clinic-linked diagnostics | Existing clinics offer suitable tests or connect patients to diagnostic providers. | Clinical oversight, integration with consultations and follow-up. |
Community entrepreneur network | Trained local entrepreneurs coordinate screening access and referrals. | Local relationships, supervision, and transparent incentives. |
Shared technician or mobile service | Trained personnel carry equipment across multiple villages and service points. | High utilization, route density, and manageable operating costs. |
Community kiosk or screening center | A fixed, staffed point provides recurring access to selected services. | Sufficient demand, affordable operating costs, and referral connectivity. |
Community collection with laboratory processing | Local partners collect samples for processing at spoke or central laboratories. | Sample integrity, reliable transport, and timely results. |
Government and NGO-enabled programs | Public health programs, NGOs, and private providers coordinate screening and referral. | Committed funding, implementation capacity, and continuity beyond pilots. |
Managed diagnostic network | A startup supports multiple partner sites with technology, consumables, training, quality assurance, and maintenance. | Repeat utilization, standardized operations, and recurring revenue. |
These models can operate together or independently. For example, a startup could use pharmacies as local access points, shared technicians for selected tests, and a central laboratory for specialized investigations.
The objective is to select the model that best fits the technology and community, not to force every solution into the same distribution structure.
How to select the right community model
The operating model should be designed around five practical considerations:
Community access: Where do people already seek care, and which local institutions do they trust?
Service requirements: Can the test be performed safely at the community level, or does it require specialized lab infrastructure?
Demand and utilization: Is demand sufficient to support the equipment, personnel, and consumables?
Referral and follow-up: Can patients access confirmatory testing and appropriate continuing clinical care?
Partner and payer economics: Who operates the service, who benefits, who pays, and what sustains participation?
Where demand is intermittent, mobile or shared services may be preferable to dedicated equipment at every location. Where specialized processing is required, local collection linked to a laboratory may be more appropriate.
Government, NGO, and CSR partnerships can help establish access in underserved locations, but the long-term funding and operating model must be explicit.
Community readiness is not the same as technology validation
Taking an unproven diagnostic technology into a community can create serious consequences. In a discussion with a potential donor partner, a key concern was that unreliable outputs could undermine community trust, program outcomes, institutional credibility, and the funder's reputation.
Communities should not become the first real test of whether a diagnostic technology works.
Deployment must include suitable quality controls, trained operators, and referral or confirmatory-testing pathways where needed. However, validation is only one part of the journey.
Communities as distribution channels
Once a technology has demonstrated sufficient performance for its intended use, the next question is whether it can become part of a sustainable community-level delivery network.
Can local pharmacies, clinics, entrepreneurs, or community organizations help distribute the service? Will people use it frequently? Can partners sustain community participation? Can the service reach more communities without compromising quality or affordability?
These are questions of distribution strategy, adoption, and business model design.
The pathway should be:
Early community engagement can help establish needs, usability, and workflows, but it should have a clearly defined purpose and appropriate safeguards.
Assessment framework for community-driven model
A successful pilot is a starting point, not proof of a scalable business. Stronger evidence comes from repeat utilization, reliable service delivery, completed referrals, repeat orders or procurement, and sustainable cost per actionable result.
Thesis: Build the channel around the technology
Community-level diagnostics depend on how effectively validated solutions are embedded in trusted local networks, connected to appropriate clinical care, and supported by sustainable operating models.
For founders, the challenge is to build a distribution strategy that works for the community and the business. A promising startup should be able to demonstrate not only that its technology works, but also:
Where it will be deployed and who will operate it.
How it will reach patients through local access points.
Why community partners will continue participating.
Who pays for screening and follow-up services.
How the model maintains quality as it expands.
The ultimate question is not merely whether a diagnostic technology works, but whether it can become a trusted, accessible, and sustainable service within the community.
The models that answer this question convincingly may offer a pathway to expanding access across India's underserved populations.
Note
This is an ongoing exploration of community-driven healthcare delivery and sustainable business models. If you have come across interesting models, experiences, or insights on community-level adoption, I’d love to hear your thoughts and recommendations at venture@jaipur.vc.
